Licitra Lisa, Bernier Jacques, Grandi Cesare, Locati Laura, Merlano Marco, Gatta Gemma, Lefebvre Jean-Louis
START Project, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Crit Rev Oncol Hematol. 2003 Jul;47(1):65-80. doi: 10.1016/s1040-8428(03)00017-9.
In Europe, laryngeal cancer accounts for only 2-5% of all cancers, the incidence being much higher among males than among females. Smoke and alcohol represent the major behavioural risk factors. Several carcinogens, occupations and vitamin deficiencies have been associated with laryngeal cancer. A genetic susceptibility to environmental risk factors and carcinogens is recognized. Hoarseness is the main symptom for which patients call for medical consultation. Mucosa is the most common histologic site of the primary lesions considered in the present chapter. Nodal involvement, the site and volume of the primary tumour, and some genes expression represent the major prognostic factors. A high death rate for not cancer-related events is to be pointed out. The loco-regional extent of the disease determines the success of cure. Surgery and radiotherapy represent the main therapeutic options. The choice between these two procedures is often controversial.
在欧洲,喉癌仅占所有癌症的2%至5%,男性发病率远高于女性。吸烟和饮酒是主要的行为风险因素。多种致癌物、职业因素以及维生素缺乏都与喉癌有关。人们认识到对环境风险因素和致癌物存在遗传易感性。声音嘶哑是患者寻求医疗咨询的主要症状。本章所考虑的原发性病变最常见的组织学部位是黏膜。淋巴结受累情况、原发肿瘤的部位和体积以及一些基因表达是主要的预后因素。需要指出的是,非癌症相关事件的死亡率较高。疾病的局部区域范围决定了治愈的成功率。手术和放疗是主要的治疗选择。这两种治疗方法之间的选择往往存在争议。